Japanese Circulation Journal · 1979 · 10 citations · 17 references
MedicineNephrologyPharmacologyDialysisHemodialysisNeuropharmacologyChronic Kidney DiseaseRenal DiseaseRenal ImpairmentRenal PharmacologyRenal PhysiologyBlood PressureChronic Renal InsufficiencySympathetic ActivationSympathetic Nervous System InvolvementSympathetic Nervous System ModulationSympathetic Nervous System PharmacologySympathetic Nervous System PhysiologySystolic Blood Pressure
To evaluate the activity of the sympathetic nervous system in chronic renal failure, plasma norepinephrine (NE) and dopamine-beta-hydroxylase (DBH) activity were measured by a radioenzymatic assay and a photometric assay respectively. The level of plasma NE was significantly higher in 14 patients with hemodialysis than in healthy individuals (p less than 0.001). The level of plasma NE fell significantly in 6 patients with hemodialysis receiving 0.30-0.45 mg/day of clonidine hydrochloride (a depressor of the sympathetic outflow from the central nervous system) (p less than 0.05). Systolic blood pressure was correlated with the level of plasma NE in patients with hemodialysis who were not receiving clonidine. They had high level of plasma NE and low level of plasma DBH activity. Therefore, this findings suggest that high level of plasma NE in chronic renal failure is caused not only by decreased urinary excretion, but also by increased overflow from the sympathetic nervous clefts.
17
A sensitive radioenzymatic assay for norepinephrine in tissues and plasma
David P. Henry, Barbra J. Starman, David G. Johnson et al. · Life Sciences · 1975 · 475 citations